Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs

Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs

US Patent 7405230 · Granted Jul 29, 2008

Estimated economic value: $620,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Process for making beta 3 agonists and intermediates2023
Creatine prodrugs, compositions and methods of use thereof2023
Process for making beta 3 agonists and intermediates2023
Compositions and methods for treating infections2022
CDPK1 inhibitors, compositions, and methods related thereto2022
Creatine prodrugs, compositions and methods of use thereof2022
Creatine prodrugs, compositions and methods of use thereof2022
Process for making beta 3 agonists and intermediates2021
Creatine phosphate analog prodrugs, compositions and methods of use thereof2021
Process for making beta 3 agonists and intermediates2021
Compositions and methods for treating infections2020
Process for making beta 3 agonists and intermediates2020